Novo Nordisk A/S Common Stock (NY:NVO)
Price and Volume
Detailed Quote| Volume | 7,833,051 |
| Open | 37.57 |
| Bid (Size) | 38.28 (900) |
| Ask (Size) | 38.29 (800) |
| Prev. Close | 37.53 |
| Today's Range | 37.51 - 38.47 |
| 52wk Range | 35.12 - 64.16 |
| Shares Outstanding | N/A |
| Dividend Yield | 3.02% |
Top News
More News
Performance
52-Week Range
40.3% below 52-week high
38.28
35.1252W Low
64.1652W High
1 Week
1.3% below 1-week high
36.841W Low
38.771W High
Novo Nordisk A/S Common Stock (NVO) traded between $35.12 and $64.16 over the past 52 weeks and last traded at $38.28, 40.3% below its 52-week high. Over the past week it ranged between $36.84 and $38.77.
Past 12 Months
+1.0%
-15.2%
-22.9%
+3.7%
-26.9%
-35.8%
1W
+$0.38
1M
-$6.88
3M
-$11.36
6M
+$1.38
YTD
-$14.11
1Y
-$21.37
NVO was -35.8% over the past year, +3.7% over six months, -26.9% year to date, +1.0% in the last week.
12 Months vs Market
NVO
-35.8%
DIA
+9.5%
SPY
+15.6%
QQQ
+24.4%
IWM
+12.6%
Over the past 12 months NVO returned -35.8% versus DIA (Dow) +9.5%, SPY (S&P 500) +15.6%, QQQ (Nasdaq 100) +24.4% and IWM (Russell 2000) +12.6%.
Volume & Liquidity
0.63× 3-mo avg
Today 7,833,051
3-mo avg 12.5M
1W
15.4M
1M
14.6M
3M
12.5M
6M
13.7M
YTD
17.1M
1Y
17.0M
NVO most recently traded 7,833,051 shares against a 3-month average daily volume of 12.5M.
More News
Read More
Better High-Yield Dividend Stock: Pfizer or Novo Nordisk? ↗
October 04, 2026
Via The Motley Fool
Via The Motley Fool
Topics
Intellectual Property
Novo Is Open to Acquisitions. Here Are 2 Companies That Would Be Great Candidates to Buy ↗
September 30, 2026
Via The Motley Fool
Topics
Initial Public Offering
3 Emerging Biotech Stocks With Significant Upside Potential ↗
September 30, 2026
Via MarketBeat
Topics
Intellectual Property
4 Stocks That Could Split Next—and Why Investors Are Watching ↗
September 30, 2026
Via MarketBeat
Topics
Artificial Intelligence
Novo Nordisk Gives Uninspiring Outlook ↗
September 29, 2026
Via The Motley Fool
Opinion: Eli Lilly Stock Is a No-Brainer Pick to Buy on the Dip ↗
September 29, 2026
Via The Motley Fool
Eli Lilly Just Announced Game-Changing News ↗
September 28, 2026
Via The Motley Fool
Here's Where Wall Street Analysts See Eli Lilly's Share Price Going ↗
September 26, 2026
Via The Motley Fool
Via The Motley Fool
Topics
Intellectual Property
Could This Be Novo Nordisk’s Next Billion-Dollar Weight-Loss Product? ↗
September 25, 2026
Via The Motley Fool
AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026? ↗
September 24, 2026
Via The Motley Fool
Topics
Intellectual Property
Viking's Obesity Edge May Be Staying Power, Not Weight Loss ↗
September 23, 2026
Via MarketBeat
Eli Lilly Keeps Pulling Ahead—Can Novo Nordisk Catch Up? ↗
September 23, 2026
Via MarketBeat
Why Viking Therapeutics Stock Skyrocketed on Tuesday ↗
September 23, 2026
Via The Motley Fool
Via The Motley Fool
Novo Nordisk Targets Five Multi-Blockbusters by 2030 as Oral Wegovy Gains Traction ↗
September 21, 2026
Via MarketBeat
Why Novo Nordisk Stock Just Crashed ↗
September 21, 2026
Via The Motley Fool
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 38.28
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 10/07/26 12:30 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>